Nuvation Bio, Inc. (NUVB)
5.85
-0.29
(-4.72%)
USD |
NYSE |
Jan 16, 16:00
5.85
0.00 (0.00%)
Pre-Market: 20:00
Nuvation Bio Shareholders Equity (Quarterly): 325.88M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Indivior PLC | -207.00M |
| Terns Pharmaceuticals, Inc. | 284.07M |
| GRAIL, Inc. | 2.240B |
| Arrowhead Pharmaceuticals, Inc. | 466.05M |
| Corcept Therapeutics, Inc. | 631.90M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 601.56M |
| Total Liabilities (Quarterly) | 275.68M |
| Debt to Equity Ratio | 0.6387 |
| Current Ratio | 8.477 |
| Net Debt Paydown Yield | 1.28% |